Journal of Experimental Medicine (JEM) publishes papers providing novel conceptual insight into immunology, neuroscience, cancer biology, vascular biology, microbial pathogenesis, and stem cell biology. All editorial decisions are made by active scientists in conjunction with professional editors. JEM was established in 1896. Carl Nathan and Michel Nussenzweig serve as JEM Editorial Board Co-Chairs. Dr. Nathan is the R.A. Rees Pritchett Professor and Chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine. Dr. Nussenzweig is the Zanvil A. Cohn and Ralph M. Steinman Professor at The Rockefeller University, Investigator at Howard Hughes Medical Institute, and Senior Physician. Teodoro Pulvirenti serves as JEM Executive Editor. Learn more about JEM editors.

Celebrating 125 years of enduring studies in medical biology: visit the JEM Anniversary hub.

Why submit your research to JEM?

At JEM, all editorial decisions on research manuscripts are made through collaborative consultation between professional scientific editors and the academic editorial board. JEM implements editorial policies with highly productive investigators in mind.

Format Neutral: You may submit your papers in ANY format.

Transfer Policy: We welcome submissions that include reviewer comments from another journal. You may also request manuscript transfer between Rockefeller University Press journals, and we can confidentially send reviewer reports and identities to another journal beyond RUP.

Fair and Fast: We limit rounds of revision, and we strive to provide clear, detailed decisions that illustrate what is expected in the revisions. Articles appear online one to two days after author proofs are returned.

Open Access Options: Our options include Immediate Open Access (CC-BY) and open access six months after publication (CC-BY-NC-SA).

JEM Highlights:

• 92% of invited revisions are accepted
• initial decision in 6 days
• time in peer review 38 days

Learn more about submitting your research to JEM